This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Horizon Therapeutics USA, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Jeffrey D. Kent
Introduction
Jeffrey D. Kent is an accomplished inventor based in Deerfield, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of gout. With a total of 2 patents to his name, Kent's work focuses on innovative therapies that enhance patient outcomes.
Latest Patents
Kent's latest patents include groundbreaking methods for treating gout. One of his notable inventions is titled "Combination Therapies of Prednisone and Uricase Molecules and Uses Thereof." This patent outlines methods for reducing immunogenicity to pegloticase, a PEGylated uricase. The disclosure provides various methods of treating gout in patients, including the co-administration of a PEGylated uricase and methotrexate (MTX). Additionally, it describes methods for prolonging the urate-lowering effect through the same co-administration strategy.
Career Highlights
Jeffrey D. Kent is currently associated with Horizon Therapeutics USA, Inc., where he continues to develop innovative solutions for patients suffering from gout. His expertise and dedication to research have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Kent collaborates with various professionals in his field, including his coworker John Botson. Their combined efforts contribute to the advancement of therapeutic strategies in treating gout.
Conclusion
Jeffrey D. Kent's contributions to the field of medicine through his patents and work at Horizon Therapeutics USA, Inc. highlight his commitment to improving patient care. His innovative approaches in treating gout demonstrate the impact of dedicated research and collaboration in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile